PMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Psychemedics's Dividends per Share for the three months ended in Mar. 2024 was $0.00.
The historical rank and industry rank for Psychemedics's 3-Year Dividend Growth Rate or its related term are showing as below:
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Psychemedics was 26.00% per year. The lowest was -58.30% per year. And the median was 1.10% per year.
During the past 12 months, Psychemedics's average Dividends Per Share Growth Rate was -75.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -8.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -30.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Psychemedics's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Psychemedics's Dividend Yield % is 2.72%.
For more information regarding to dividend, please check our Dividend Page.
For the Diagnostics & Research subindustry, Psychemedics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Psychemedics's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Psychemedics's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Psychemedics (NAS:PMD) 3-Year Dividend Growth Rate Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Psychemedics's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Mar. 2024 ) | / | EPS without NRI (Q: Mar. 2024 ) |
= | 0 | / | -0.12 | |
= | N/A |
During the past 13 years, the highest Dividend Payout Ratio of Psychemedics was 2.57. The lowest was 0.49. And the median was 1.00.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of Psychemedics was 14.69%. The lowest was 0.66%. And the median was 4.07%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shannon Shoemaker | officer: Chief Revenue Officer | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Charles M Doucot | officer: Executive Vice President | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Andrew Reynolds | director | C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451 |
Brian Hullinger | director, officer: President & CEO | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Robyn C Davis | director | ONE WALLINGFORD ROAD, MARBLEHEAD MA 01945 |
Michael Weisenhoff | other: Assistant Controller | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Michael I Schaffer | officer: VP of Laboratory Operations | C/O PAYCHEMEDICS CORP, 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138 |
William B. Norris | other: Assistant Controller | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Darius G Nevin | other: See Footnote 1 | C/O WCI COMMUNITIES, INC., 24301 WALDEN CENTER DRIVE, BONITA SPRINGS FL 34134 |
Peter H Kamin | 10 percent owner | 2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410 |
Andrew Limbek | officer: Vice President & Controller | 289 GREAT ROAD, SUITE 200, ACTON MA 01720 |
Fred J Weinert | director | 330 E MAIN ST, BARRINGTON IL 60620 |
Kubacki Raymond C Jr | director, officer: Chairman, CEO & President | 125 NAGOG PARK, ACTON MA 01720 |
A Clinton Allen | director, officer: Chairman | 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138 |
Neil Lerner | officer: VP - Finance | C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON MA 01720 |
From GuruFocus
By sperokesalga sperokesalga • 03-21-2023
By GlobeNewswire GlobeNewswire • 05-10-2022
By Marketwired • 08-18-2023
By GlobeNewswire GlobeNewswire • 08-09-2022
By GuruFocusNews GuruFocusNews • 07-09-2022
By sperokesalga sperokesalga • 05-09-2023
By GlobeNewswire GlobeNewswire • 05-09-2023
By GuruFocusNews GuruFocusNews • 06-29-2022
By GlobeNewswire GlobeNewswire • 03-21-2023
By GuruFocusNews GuruFocusNews • 06-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.